Spine Biologics Market Report by Product (Spinal Allografts, Bone Graft Substitutes, Cell Based Matrix), Surgery Type (Open Spine Surgery, Minimally Invasive Spine Surgery), End User (Hospitals, Ambulatory Care Centers, Spinal Surgery Centers, Orthopedic Clinics, and Others), and Region 2023-2028
The global spine biologics market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.79% during 2022-2028.
Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.
Spine Biologics Market Trends:
Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, surgery type and end user.
Breakup by Product:
Spinal Allografts
Machined Bones Allograft
Demineralized Bone Matrix
Bone Graft Substitutes
Bone Morphogenetic Proteins
Synthetic Bone Grafts
Cell Based Matrix
Breakup by Surgery Type:
Open Spine Surgery
Minimally Invasive Spine Surgery
Breakup by End User:
Hospitals
Ambulatory Care Centers
Spinal Surgery Centers
Orthopedic Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.
Key Questions Answered in This Report
1. How big is the global spine biologics market?
2. What is the expected growth rate of the global spine biologics market during 2023-2028?
3. What are the key factors driving the global spine biologics market?
4. What has been the impact of COVID-19 on the global spine biologics market?
5. What is the breakup of the global spine biologics market based on the product?
6. What is the breakup of the global spine biologics market based on the surgery type?
7. What is the breakup of the global spine biologics market based on the end user?
8. What are the key regions in the global spine biologics market?
9. Who are the key players/companies in the global spine biologics market?
Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.
Spine Biologics Market Trends:
Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, surgery type and end user.
Breakup by Product:
Spinal Allografts
Machined Bones Allograft
Demineralized Bone Matrix
Bone Graft Substitutes
Bone Morphogenetic Proteins
Synthetic Bone Grafts
Cell Based Matrix
Breakup by Surgery Type:
Open Spine Surgery
Minimally Invasive Spine Surgery
Breakup by End User:
Hospitals
Ambulatory Care Centers
Spinal Surgery Centers
Orthopedic Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.
Key Questions Answered in This Report
1. How big is the global spine biologics market?
2. What is the expected growth rate of the global spine biologics market during 2023-2028?
3. What are the key factors driving the global spine biologics market?
4. What has been the impact of COVID-19 on the global spine biologics market?
5. What is the breakup of the global spine biologics market based on the product?
6. What is the breakup of the global spine biologics market based on the surgery type?
7. What is the breakup of the global spine biologics market based on the end user?
8. What are the key regions in the global spine biologics market?
9. Who are the key players/companies in the global spine biologics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL SPINE BIOLOGICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Spinal Allografts
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Machined Bones Allograft
6.1.2.2 Demineralized Bone Matrix
6.1.3 Market Forecast
6.2 Bone Graft Substitutes
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Bone Morphogenetic Proteins
6.2.2.2 Synthetic Bone Grafts
6.2.3 Market Forecast
6.3 Cell Based Matrix
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY SURGERY TYPE
7.1 Open Spine Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Minimally Invasive Spine Surgery
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Spinal Surgery Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedic Clinics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arthrex Inc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Alphatec Holdings Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Exactech Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Medtronic plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 NuVasive Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Orthofix Medical Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Stryker Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Wright Medical Group N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Zimmer Biomet
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL SPINE BIOLOGICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Spinal Allografts
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Machined Bones Allograft
6.1.2.2 Demineralized Bone Matrix
6.1.3 Market Forecast
6.2 Bone Graft Substitutes
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Bone Morphogenetic Proteins
6.2.2.2 Synthetic Bone Grafts
6.2.3 Market Forecast
6.3 Cell Based Matrix
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY SURGERY TYPE
7.1 Open Spine Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Minimally Invasive Spine Surgery
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Spinal Surgery Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedic Clinics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arthrex Inc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Alphatec Holdings Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Exactech Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Medtronic plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 NuVasive Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Orthofix Medical Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Stryker Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Wright Medical Group N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Zimmer Biomet
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2023-2028
Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Spine Biologics Market: Competitive Structure
Table 7: Global: Spine Biologics Market: Key Players
Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2023-2028
Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Spine Biologics Market: Competitive Structure
Table 7: Global: Spine Biologics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2022
Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2022
Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2022
Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2022
Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Spine Biologics Industry: SWOT Analysis
Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis
Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2022
Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2022
Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2022
Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2022
Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Spine Biologics Industry: SWOT Analysis
Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis
